Business Context and Reporting Period
Company: Prospect Capital Corporation (PSEC)
Filing Type: Form 8-K (Current Report)
Report Date: June 14, 2021
Event Date: June 11, 2021
Context: The filing reports the results of a Special Meeting of Stockholders held virtually to vote on a specific corporate proposal regarding future equity offerings.
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.
Material Changes
The material change reported is the successful shareholder approval of a proposal to authorize the Company to sell shares of its common stock at a price below its then-current net asset value (NAV) per share. This authorization is valid for the next 12 months, subject to Board of Directors approval and specific conditions, including a limit that shares sold on any given date do not exceed 25% of outstanding common stock immediately prior to such sale.
Voting Results and Management Commentary
Proposal 1 Results:
The proposal was approved by the stockholders. The final voting results were as follows:
- Total Votes For: 210,939,316
- Total Votes Against: 32,919,267
- Total Votes Abstained: 6,529,657
- Broker Non-Votes: 0
Adjusted Results (Excluding Affiliated Shares):
After adjusting for 106,537,303 affiliated shares, the vote was:
- For: 104,402,013
- Against: 32,919,267
- Abstained: 6,529,657
Record Date Data: As of March 15, 2021, 389,518,023 shares were eligible to vote, including 108,131,739 shares owned by affiliates.
Investor Verification Checklist
- Verify the specific conditions and limitations for the below-NAV share sales as detailed in the definitive proxy statement filed on March 15, 2021.
- Confirm the Company's current Net Asset Value (NAV) per share to understand the pricing threshold for future offerings.
- Monitor future Board of Directors approvals required to execute any specific share sales under this new authorization.
- Review the impact of potential dilution given the 25% per-day sale limit on outstanding common stock.